# Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease

> **NCT04858074** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Ibadan** · enrollment: 19 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Hypoestoxide

## Key facts

- **NCT ID:** NCT04858074
- **Lead sponsor:** University of Ibadan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-03
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858074, "Study to Investigate the Effect of Hypoestes Rosea Powder in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04858074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*